DACS
GILD icon

Dymon Asia Capital (Singapore)’s Gilead Sciences GILD Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Buy
80,000
+50,000
+167% +$6.59M 0.42% 33
2026
Q1 		$4.18M Buy
+30,000
New +$4.2M 0.43% 67
2025
Q3 		– Sell
-18,000
Closed -$2.05M – 273
2025
Q2 		$2M Buy
+18,000
New +$1.92M 0.28% 75

Other funds holding GILD

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s GILD Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) increased its Gilead Sciences (GILD) stake by 167% in Q2 2026, buying an estimated $6.59M and bringing the position to 80,000 shares worth $10.1M. The position accounts for 0.42% of the portfolio, ranked #33.

Dymon Asia Capital (Singapore) first reported a position in GILD in Q2 2025 and has held it in 3 quarters since. 1,201 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Dymon Asia Capital (Singapore) held 80,000 shares of Gilead Sciences worth $10.1M as of Q2 2026.
  • Dymon Asia Capital (Singapore) bought 50,000 Gilead Sciences shares in Q2 2026, an estimated $6.59M.
  • Gilead Sciences made up 0.42% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #33 holding.
  • Dymon Asia Capital (Singapore) first reported a position in Gilead Sciences in Q2 2025 and has held it in 3 quarters since.
  • 1,201 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.